Clinical outcomes of image guided radiation therapy (IGRT) with gold fiducial vaginal cuff markers for high-risk endometrial cancer

References

• Scholten AN, van Putten WL, Beerman H, Smit VT, Koper PC, Lybeert ML, et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathologic review. Int J Radiat Oncol Biol Phys 2005;63:834–8.
   PubMed Web of Science ®Google Scholar
• Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744–51.
   PubMed Web of Science ®Google Scholar
• Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419–27.
   PubMed Web of Science ®Google Scholar
• ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, Kitchener H, Whelan T, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis. Lancet 2009;373:125–36.
   PubMedGoogle Scholar
• Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. J Clin Oncol 2006;24:36–44.
   PubMed Web of Science ®Google Scholar
• Maggi R, Lissoni A, Spina F, Melpignano M, Zola P, Favalli G, et al. Adjuvant chemotherapy vs. radiotherapy in high-risk endometrial carcinoma: Results of a randomized trial. Br J Cancer 2006;96:266–71.
   Google Scholar
• Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ. Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 2009; 115:6–11.
   PubMed Web of Science ®Google Scholar
• Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000;48:1613–21.
   PubMed Web of Science ®Google Scholar
• Igdem S, Ercan T, Alco G, Zengin F, Ozgules R, Geceer G, et al. Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy in patients with gynecologic malignancies. Eur J Gynaecol Oncol 2009;30:547–51.
   PubMed Web of Science ®Google Scholar
• Yang R, Xu S, Jiang W, Wang J, Xie C. Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy. Acta Oncol 2010;49:230–6.
   PubMed Web of Science ®Google Scholar
• Heron DE, Gerszten K, Selvaraj RN, King GC, Sonnik D, Gallion H, et al. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: A comparative dosimetric study of dose-volume histograms small star, filled. Gynecol Oncol 2003;91:39–45.
   PubMed Web of Science ®Google Scholar
• Chan P, Yeo I, Perkins G, Fyles A, Milosevic M. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: A retrospective planning study. Radiat Oncol 2006;1:13.
   PubMedGoogle Scholar
• Georg P, Georg D, Hillbrand M, Kirisits C, Potter R. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. Radiother Oncol 2006;80:19–26.
   PubMed Web of Science ®Google Scholar
• Lian J, Mackenzie M, Joseph K, Pervez N, Dundas G, Urtasun R, et al. Assessment of extended-field radiotherapy for stage IIIC endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy. Int J Radiat Oncol Biol Phys 2008;70:935–43.
   PubMed Web of Science ®Google Scholar
• Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003;56:1354–60.
   PubMed Web of Science ®Google Scholar
• Salama JK, Mundt AJ, Roeske J, Mehta N. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006;65:1170–6.
   PubMed Web of Science ®Google Scholar
• Tierney RM, Powell MA, Mutch DG, Gibb RK, Rader JS, Grigsby PW. Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer. Radiat Med 2007;25:439–45.
   PubMedGoogle Scholar
• Bouchard M, Nadeau S, Gingras L, Raymond PE, Beaulieu F, Beaulieu L, et al. Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:1343–50.
   PubMed Web of Science ®Google Scholar
• Kim CR, Eaton BA, Stevens DR Jr.Localization of the apex of the vagina: Implications for radiation therapy planning. Radiology 1999;212:155–8.
   PubMed Web of Science ®Google Scholar
• Ma DJ, Michaletz-Lorenz M, Goddu SM, Grigsby PW. Magnitude of interfractional vaginal cuff movement: Implications for external irradiation. Int J Radiat Oncol Biol Phys 2012;82:1439–44.
   PubMed Web of Science ®Google Scholar
• Radiation Therapy Oncology Group website. Available from: http//www.rtog.org/CoreLab/ContouringAtlases/GYN
   Google Scholar
• Harris EE, Latifi K, Rusthoven C, Javedan K, Forster K. Assessment of organ motion in postoperative endometrial and cervical cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2011;81:e645–50.
   Web of Science ®Google Scholar
• Kim H, Beriwal S, Huq MS, Kannan N, Shukla G, Houser C. Evaluation of set-up uncertainties with daily kilovoltage image guidance in external beam radiation therapy for gynecological cancers. Clin Oncol (R Coll Radiol) 2012;24:e39–45.
   PubMedGoogle Scholar
• Lin L, Hertan L, Rengan R, Teo BK. Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys 2012;83:670–5.
   PubMed Web of Science ®Google Scholar
• Jurgenliemk-Schulz IM, Toet-Bosma MZ, de Kort GA, Schreuder HW, Roesink JM, Tersteeg RJ, et al. Internal motion of the vagina after hysterectomy for gynaecological cancer. Radiother Oncol 2011;98:244–8.
   PubMed Web of Science ®Google Scholar
• Scotti V, Borghesi S, Meattini I, Saieva C, Rossi F, Petrucci A, et al. Postoperative radiotherapy in stage I/II endometrial cancer. Retrospective analysis of 883 patients treated at the University of Florence. Int J Gynecol Cancer 2010;20:1540–8.
   PubMed Web of Science ®Google Scholar
• Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T. Preliminary analysis of RTOG9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.Int J Radiat Oncol Biol Phys2004;59:168–73.
   Google Scholar
• Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T. Final analysis of RTOG9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.Gynecol Oncol2006;103:155–9.
   Google Scholar